A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine

Recruiting

Phase 1

Lu AG09222 & UbrogepantA Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine

Sponsor:

H. Lundbeck A/S

Code:

NCT06578585

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Ubrogepant

Lu AG09222

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-16. This information was provided to ClinicalTrials.gov by H. Lundbeck A/S on 2025-02-14.